Abstract Submission

ILCA 2019 / Abstracts / Abstract Submission

Abstract submission is now closed

ILCA sincerely thanks everyone around the world who have submitted an abstract for ILCA 2019.

The review process will start shortly. All abstracts will be reviewed and rated by an international team of renowned experts in liver cancer. Notifications of acceptance or rejection will be sent out via email by end of May 2019. If you have any queries, please contact the ILCA Office at info@ilca-online.org.

e-Posters and Paper posters

e-Posters have replaced the printed posters at the conference. Authors will have the opportunity to submit an electronic version of their poster, or prepare a number of slides, which will be displayed on touch screens in the poster area.


A specific e-Poster Viewing Tour will be held on Saturday, 21 September and will be partly focusing on 30 top-scored abstracts within each session, which will be shown as e-Poster as well as on a static panel as paper board poster. This tour will be opened by one of the ILCA prominent scientists.

e-Poster/Paper poster presenters will receive an email with instructions on where and how to submit their e-Poster/Paper poster presentation following acceptance of their abstract.

Oral Communications

A number of abstracts will be selected to be presented as an oral communication in a general session. Presentation will include a 10-minute presentation plus 5 minutes Q&A for each presenter.

Contact Us

Keep Me Updated

By continuing to browse this website, you accept cookies which are used to offer a personalized experience on our website, generate statistics and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.